The Clinical and Biomarker Association of Programmed Death Ligand 1 and its Spatial Heterogeneous Expression in Colorectal Cancer

Background: Programmed death ligand 1 (PD-L1) expression has been shown to predict benefit from anti-PD-1 treatment in several cancers. However, its predictive value in colorectal cancer seems limited. This study was aimed to explore the clinical and biomarker association of programmed death ligand...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Xiao-Li, Wu, Qi-Nian, Chen, Dong-liang, Zeng, Zhao-Lei, Lu, Jia-Bin, Liu, Ze-Xian, Ju, Huai-Qiang, Ren, Chao, Pan, Zhi-Zhong, Wang, Feng-Hua, Xu, Rui-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277645/
https://www.ncbi.nlm.nih.gov/pubmed/30519336
http://dx.doi.org/10.7150/jca.27735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277645/
https://www.ncbi.nlm.nih.gov/pubmed/30519336
http://dx.doi.org/10.7150/jca.27735

Ejemplares similares